Clinical Trials Logo

Peripheral Vascular Diseases clinical trials

View clinical trials related to Peripheral Vascular Diseases.

Filter by:

NCT ID: NCT06020534 Completed - Clinical trials for Peripheral Arterial Disease

Aortoiliac Stenosis in Kidney Transplantation

TASC
Start date: January 1, 2022
Phase:
Study type: Observational

The impact of aortoiliac stenosis on kidney transplant patients remains unclear. This study aims to investigate the safety and efficacy of kidney transplantation in patients with aortoiliac stenosis.

NCT ID: NCT06014242 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

Peripheral Microvascular Resistance as a Predictor for Limb Salvage

Start date: July 25, 2024
Phase: N/A
Study type: Interventional

Salvaging a threatened limb is the key therapeutic objective for patients with critical limb ischemia, and the achievement of limb salvage is an independent predictor of patient morbidity and mortality. Despite successful primary endovascular or surgical intervention, the corresponding symptoms of rest pain and/or non-healing ulceration in some patients may continue, and amputation in these patients is unavoidable. It is hypothesized that the functional integrity of the peripheral vascular microcirculation may be impaired in these patients. However, there are currently no techniques that allow direct quantification and visualization of the microcirculation due to the micro-vessel invisibility under angiography. In the coronary circulation, coronary flow reserve (CFR) indicates the capacity for maximal hyperemic blood flow and reveals impaired coronary microvascular function. Studies have shown the clinical significance of measuring microvascular resistance to predict myocardial salvage after myocardial infarction. The study will explore whether this concept of coronary flow reserve can be applied peripherally to patients with critical limb ischemia in order to determine whether measuring peripheral vascular flow reserve can determine the integrity of the microcirculation to predict limb salvage after endovascular intervention.

NCT ID: NCT06009276 Recruiting - Clinical trials for Overweight and Obesity

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

Start date: August 30, 2023
Phase:
Study type: Observational

The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness status impacts the bacteria that are present in the oral microbiome (environment in the mouth) or the ability of the body to send blood to the skeletal muscle. Participants will complete all or some of the following: - A mouth swab to assess the bacteria in their mouths. - Produce a saliva sample into a tube. - Cycle on a bike until you reach maximum effort. - Undergo blood draws - Wear a 24-hour non-invasive device that monitors blood pressure. - Undergo a test to assess blood flow to the muscles measured with an ultrasound. - Drink 70mL (1/3 of a cup) of concentrated beetroot juice once

NCT ID: NCT06001203 Recruiting - Clinical trials for Peripheral Arterial Disease

Foot Reflexology and Pain and Ankle Brachial Index

Start date: July 15, 2023
Phase: N/A
Study type: Interventional

This randomized controlled study aimed to determine the effect of foot reflexology on pain and ankle brachial index level in patients with peripheral artery disease

NCT ID: NCT05999669 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

Predictive Value of the Global Limb Anatomic Staging System (GLASS) in Patients With Critical Limb-threatening Ischemia

Start date: August 20, 2023
Phase:
Study type: Observational

The Global Vascular Guideline on chronic limb threatening ischemia (CLTI) proposes the Global Limb Anatomic Staging System (GLASS), a new angiographic scoring system to quantify the anatomic severity of infrainguinal disease in CLTI patients. However, GLASS validation still needs to be completed, and the infrapopliteal (IP) target artery pathway (TAP) was easily influenced by the procedures. Thus the IP target artery could be selected either as the least diseased artery based on angiography or prospectively based on the angiosome concept. So the investigators aim to evaluate its correlation with clinical outcomes after revascularization.

NCT ID: NCT05992896 Recruiting - Clinical trials for Peripheral Arterial Disease

A Study of Loco-Regional Liposomal Bupivacaine Injection

Start date: September 26, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.

NCT ID: NCT05961943 Recruiting - Clinical trials for Peripheral Arterial Disease

RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients

Start date: September 29, 2023
Phase: N/A
Study type: Interventional

The RESPONSE-2- peripheral arterial disease (PAD) program will be implemented to modify sedentary time in patients with PAD. It is an adapted version of the RESPONSE that aims to reduce sedentary behavior in individuals with diabetes. The RESPONSE-2-PAD is a multicomponent program involves an online educational component, sedentary reminders and health coaching sessions, which are designed to modify patients' sedentary behavior.

NCT ID: NCT05921461 Completed - Diabetes Mellitus Clinical Trials

The Use of HOVR Technology for Assessment of Blood Associated Parameters

Start date: May 1, 2022
Phase:
Study type: Observational

Feasibility, usability and safety clinical study that is aimed at testing of the non-invasive VOTIS PedCheck system for measurement of changes in absorption of light in order to derive changes in perfusion and oxygen levels in the foot.

NCT ID: NCT05912218 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

REducing Diabetic macrovascUlar Complications duE to Peripheral Arterial Disease- REDUCE-PAD

REDUCE-PAD
Start date: June 15, 2023
Phase: Phase 2
Study type: Interventional

This is a Phase IIa, multi-centre study conducted at 3 sites in Singapore (SGH and NUHS, KTPH). 70 patients with diabetes mellitus (DM) and peripheral arterial disease (PAD) will be randomised in a ratio 1:1 to receive normal saline control or MEDI6570 400mg by monthly subcutaneous injection for 9 months.

NCT ID: NCT05906199 Recruiting - Clinical trials for Diabetic Peripheral Angiopathy

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

Start date: July 28, 2021
Phase: Phase 4
Study type: Interventional

This study is to compare and evaluate the effect of improving the carotid IMT and lipid level of the Cilostazol/Ginkgo leaf extract group with the aspirin administrated group in patients with diabetic peripheral angiopathy.